Effect of Rivaroxaban Monotherapy vs Combination Therapy on Thrombotic and Bleeding Events in Patients With AF and Stable CAD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Rivaroxaban Monotherapy vs Combination Therapy With Antiplatelets on Total Thrombotic and Bleeding Events in Atrial Fibrillation With Stable Coronary Artery Disease: A Post Hoc Secondary Analysis of the AFIRE Trial
JAMA Cardiol 2022 Jun 15;[EPub Ahead of Print], R Naito, K Miyauchi, S Yasuda, K Kaikita, M Akao, J Ako, T Matoba, M Nakamura, N Hagiwara, K Kimura, A Hirayama, K Matsui, H OgawaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.